Use of pharmacoeconomics in prescribing research. Part 1: costs - moving beyond the acquisition price for drugs

被引：7

作者：

Robertson, J ^{[1
]}

Lang, D ^{[1
]}

Hill, S ^{[1
]}

机构：

[1] Univ Newcastle, Fac Hlth, Sch Med Practice & Populat Hlth, Newcastle, NSW 2308, Australia

来源：

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS | 2003年 / 28卷 / 01期

关键词：

economic evaluation; pharmacoeconomics;

D O I：

10.1046/j.1365-2710.2003.00452.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

This paper addresses pharmacoeconomics in prescribing research and reflects the increasing use of techniques of economic evaluation to aid drug purchasing decisions in a variety of settings - for national drug subsidization programmes, provincial purchasing plans, insurance programmes, and for hospital and area health authority formulary decisions. First, we focus on the cost component of an economic evaluation and discuss methodological issues that are relevant to all pharmacoeconomic analyses.

引用

页码：73 / 79

页数：7

共 20 条

[1] Economics notes - Handling uncertainty in economic evaluation
Briggs, A
[J]. BRITISH MEDICAL JOURNAL, 1999, 319 (7202) : 120 - 120
[2] *COMM DEP HLTH AG, 2002, SCHED PHARM BEN APPR
[3] *DEP HLTH AG CAR, 2002, GUID PHARM IND PREP
[4] Drummond M., 2015, METHODS EC EVALUATIO, V4
[5] Guidelines for authors and peer reviewers of economic submissions to the BMJ
Drummond, MF
Jefferson, TO
[J]. BRITISH MEDICAL JOURNAL, 1996, 313 (7052) : 275 - 283
[6] Glick HA, 2000, PHARMACOEPIDEMIOLOGY, V3rd
[7] HARRIS A, 1997, 51 CTR HLTH PROGR EV
[8] Problems with the interpretation of pharmacoeconomic analyses - A review of submissions to the Australian pharmaceutical benefits scheme
Hill, SR
Mitchell, AS
Henry, DA
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (16): : 2116 - 2121
[9] LARSON LN, 1996, PRINCIPLES PHARMACOE
[10] Introduction to health economics for physicians
Meltzer, MI
[J]. LANCET, 2001, 358 (9286) : 993 - 998

← 1 2 →